April 11, 2024
Adults with alcohol-related hospitalization who were discharged from the hospital with medication for alcohol use disorder (MAUD) were 51% less likely to be rehospitalized for an […]
April 11, 2024
Co-administration of a probiotic and vitamin D significantly improved cognitive function in patients with schizophrenia, results from a double-blind randomized controlled trial suggested. The combination also […]
April 10, 2024
Delerium is tied to a significantly increased risk for dementia and death in older adults, with men at particular risk, new research showed. Incident dementia risk […]
April 9, 2024
Budapest, Hungary — Twice daily intranasal oxytocin has been associated with improved social functioning, quality of life, and overall symptoms in adults with autism spectrum disorder […]
April 9, 2024
Budapest, Hungary — A single dose of intravenous esketamine during delivery or caesarean section appears to reduce the risk for postpartum depression (PPD) by more than […]
April 5, 2024
The US Food and Drug Administration (FDA) has approved the first-ever prescription app for major depressive disorder (MDD). The app, Rejoyn, was developed by Otsuka Pharmaceutical […]
April 5, 2024
Images generated by photographic computer software are the first to depict accurate images of facial distortions experienced by patients with prosopometamorphopsia (PMO), a rare visual disorder […]
April 5, 2024
New research adds to the growing evidence that metabolic health affects the brain and can adversely affect mental health. Among more than 200,000 adults, high glucose […]
April 4, 2024
Dogs can detect stress-related compounds in the breath of people experiencing early signs of trauma, including those with posttraumatic stress disorder (PTSD), a new proof-of-concept study […]